A large language model-based AI system deployed at Cleveland Clinic effectively identified diverse, eligible participants for a rare disease clinical trial through EMR screening.
Key Details
- 1Cleveland Clinic and Dyania Health used an AI system (Synapsis AI) to pre-screen for a Phase 3 trial in transthyretin amyloid cardiomyopathy (ATTR-CM).
- 2In one week, the AI reviewed 1,476 records and identified 46 potential matches; 29/30 AI-identified matches were missed by traditional methods.
- 3The AI achieved 96.2% accuracy for 7,700 trial-specific questions and a 99% negative predictive value (NPV) in excluding ineligible patients.
- 4AI-assisted recruitment led to a more diverse patient cohort, with 36.6% Black participants versus 7.1% via routine screening.
- 5Only 60% of AI-identified patients had heart failure specialist care, versus 92.8% found by traditional methods, showing improved outreach.
- 6The system used both structured EMR data and NLP to analyze clinical notes and provided auditable inclusion/exclusion justifications.
Why It Matters

Source
EurekAlert
Related News

MSKAI Unveils AI Tool for Embryo Cell Analysis and Imaging-Driven Cancer Insights
MSK researchers employ AI and advanced imaging to reveal cancer mechanisms and track embryonic development at the single-cell level.

AI-Driven Home Sensors Enable Privacy-Preserving Health Emergency Detection
Researchers have developed an AI-powered home monitoring system using radar and thermal sensors to detect health emergencies and support elderly independent living.

New Study Urges 'Green AI' Practices in Medical Imaging and Healthcare
A new review highlights the urgent need for sustainable AI practices in healthcare, with emphasis on environmental impacts from applications like medical imaging.